Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
Dow Jones Industrial Average
) is trading down 55.0 points (-0.4%) at 15,239 as of Friday, May 24, 2013, 9:35 a.m. ET. During this time, 29.3 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 594.1 million. The NYSE advances/declines ratio sits at 452 issues advancing vs. 2,052 declining with 160 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be
), which is sporting a $3.33 gain (+4.2%) bringing the stock to $82.03. Volume for Procter & Gamble currently sits at 4.1 million shares traded vs. an average daily trading volume of 8.8 million shares.
Procter & Gamble has a market cap of $216.03 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 16.1% year to date as of Thursday's close. The stock's dividend yield sits at 3.1%.
The Procter & Gamble Company, together with its subsidiaries, engages in the manufacture and sale of a range of branded consumer packaged goods. The company operates in five segments: Beauty, Grooming, Health Care, Fabric Care and Home Care, and Baby Care and Family Care. The company has a P/E ratio of 19.9, above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Procter & Gamble as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, good cash flow from operations and growth in earnings per share. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.
- You can view the full Procter & Gamble Ratings Report.
Holding back the Dow today is
), which is lagging the broader Dow index with a 34-cent decline (-1.1%) bringing the stock to $28.78. This single loss is lowering the Dow Jones Industrial Average by 2.57 points or roughly accounting for 4.7% of the Dow's overall loss. Volume for Pfizer currently sits at 1.2 million shares traded vs. an average daily trading volume of 33.5 million shares.
Pfizer has a market cap of $207.83 billion and is part of the health care sector and drugs industry. Shares are up 16.1% year to date as of Thursday's close. The stock's dividend yield sits at 3.3%.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. The company has a P/E ratio of 20.6, above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Pfizer as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
- You can view the full Pfizer Ratings Report.
Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE